组合疗法-话题@MedSci

#组合疗法#

36篇内容 | 1932人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2221014, encodeId=6953222101423, content=<a href='/topic/show?id=64655544106' target=_blank style='color:#2F92EE;'>#抗生素耐药#</a> <a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a> <a href='/topic/show?id=aeca441369f' target=_blank style='color:#2F92EE;'>#天然产物#</a>, objectTitle=Nature：打破耐药性困局，抗生素的未来！, objectType=article, longId=839373, objectId=283d8393e33e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240808/1723083734259_8538692.jpg, objectUrl=/article/show_article.do?id=283d8393e33e, replyNumber=0, likeNumber=0, createdTime=2024-08-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=283d8393e33e, moduleTitle=Nature：打破耐药性困局，抗生素的未来！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=283d8393e33e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1773073, encodeId=68961e7307325, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Cell子刊：小分子组合疗法促进心脏再生，或可治疗心梗！, objectType=article, longId=725153, objectId=c6b2e2515350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6b2e2515350, replyNumber=0, likeNumber=130, createdTime=2023-03-31, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6b2e2515350, moduleTitle=Cell子刊：小分子组合疗法促进心脏再生，或可治疗心梗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6b2e2515350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773072, encodeId=96e61e73072b7, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=J Dermatolog Treat："冷冻免疫治疗"是一种治疗多种常见尖锐湿疣的新组合疗法, objectType=article, longId=293534, objectId=14102935349d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14102935349d, replyNumber=0, likeNumber=80, createdTime=2022-02-23, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14102935349d, moduleTitle=J Dermatolog Treat："冷冻免疫治疗"是一种治疗多种常见尖锐湿疣的新组合疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14102935349d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773071, encodeId=1adc1e73071dd, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Cancer Cell：序贯组合疗法可以使治疗对侵袭性癌症患者更有效！, objectType=article, longId=216071, objectId=f5632160e196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5632160e196, replyNumber=0, likeNumber=116, createdTime=2022-01-08, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5632160e196, moduleTitle=Cancer Cell：序贯组合疗法可以使治疗对侵袭性癌症患者更有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5632160e196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773070, encodeId=9e171e730703a, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Dig Dis Sci: 普瑞巴林和抗氧化剂组合疗法在减轻慢性胰腺炎疼痛中的作用, objectType=article, longId=203609, objectId=883d2036097e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=883d2036097e, replyNumber=0, likeNumber=119, createdTime=2021-01-18, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=883d2036097e, moduleTitle=Dig Dis Sci: 普瑞巴林和抗氧化剂组合疗法在减轻慢性胰腺炎疼痛中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=883d2036097e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773069, encodeId=82271e73069f0, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功, objectType=article, longId=192743, objectId=597a192e43e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597a192e43e8, replyNumber=0, likeNumber=85, createdTime=2020-12-02, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597a192e43e8, moduleTitle=Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597a192e43e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773068, encodeId=df9e1e730682b, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=不一样的组合疗法——免疫治疗联合PARP抑制剂在肺癌的探索前景, objectType=article, longId=183964, objectId=5734183964f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5734183964f5, replyNumber=0, likeNumber=78, createdTime=2020-01-09, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5734183964f5, moduleTitle=不一样的组合疗法——免疫治疗联合PARP抑制剂在肺癌的探索前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5734183964f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773067, encodeId=b7b81e73067f9, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=FDA授予肝癌突破性疗法：免疫+靶向治疗豪华组合疗法, objectType=article, longId=177000, objectId=742f1e7000ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=742f1e7000ae, replyNumber=0, likeNumber=121, createdTime=2020-06-30, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=742f1e7000ae, moduleTitle=FDA授予肝癌突破性疗法：免疫+靶向治疗豪华组合疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=742f1e7000ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773065, encodeId=8dd31e7306543, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=欧盟监管机构批准罗氏的组合疗法（Tecentriq、阿瓦斯汀和化疗药)用于一线治疗肺癌, objectType=article, longId=161936, objectId=89ae161936ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ae161936ea, replyNumber=0, likeNumber=114, createdTime=2019-10-03, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ae161936ea, moduleTitle=欧盟监管机构批准罗氏的组合疗法（Tecentriq、阿瓦斯汀和化疗药)用于一线治疗肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89ae161936ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773064, encodeId=293c1e73064b3, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Nature Reviews Drug Discovery：如何使用免疫组合疗法治疗“冷肿瘤”和“热肿瘤”？, objectType=article, longId=158035, objectId=bc3d15803564, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc3d15803564, replyNumber=0, likeNumber=82, createdTime=2019-05-28, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc3d15803564, moduleTitle=Nature Reviews Drug Discovery：如何使用免疫组合疗法治疗“冷肿瘤”和“热肿瘤”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc3d15803564)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773066, encodeId=18b21e730660f, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Keytruda组合疗法治疗肝癌获FDA突破性疗法认定, objectType=article, longId=176162, objectId=c0101e61624e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0101e61624e, replyNumber=0, likeNumber=87, createdTime=2020-05-21, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0101e61624e, moduleTitle=Keytruda组合疗法治疗肝癌获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0101e61624e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773061, encodeId=b8291e7306146, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=2017ASH前瞻：白血病组合疗法显疗效显著提高总生存期, objectType=article, longId=122135, objectId=146112213524, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146112213524, replyNumber=0, likeNumber=73, createdTime=2018-03-13, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146112213524, moduleTitle=2017ASH前瞻：白血病组合疗法显疗效显著提高总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=146112213524)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773060, encodeId=67ec1e7306075, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=Nat Commun：加拿大科研人员发明治疗癌症的新免疫组合疗法, objectType=article, longId=120193, objectId=74a412019344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74a412019344, replyNumber=0, likeNumber=87, createdTime=2018-06-29, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74a412019344, moduleTitle=Nat Commun：加拿大科研人员发明治疗癌症的新免疫组合疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74a412019344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773062, encodeId=decf1e7306285, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=新组合疗法可提升黑色素瘤治疗效果, objectType=article, longId=124909, objectId=a34f1249094d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34f1249094d, replyNumber=0, likeNumber=153, createdTime=2018-08-16, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34f1249094d, moduleTitle=新组合疗法可提升黑色素瘤治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34f1249094d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773063, encodeId=19b61e7306317, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感, objectType=article, longId=133937, objectId=40e013393ec7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e013393ec7, replyNumber=0, likeNumber=140, createdTime=2019-03-04, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e013393ec7, moduleTitle=P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e013393ec7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773057, encodeId=c6721e73057e4, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=肿瘤免疫组合疗法Opdivo/NKTR-214开展5种肿瘤治疗研究, objectType=article, longId=79023, objectId=848de9023d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=848de9023d1, replyNumber=0, likeNumber=109, createdTime=2017-03-09, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=848de9023d1, moduleTitle=肿瘤免疫组合疗法Opdivo/NKTR-214开展5种肿瘤治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=848de9023d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773059, encodeId=b9e41e73059a9, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=AJCN：过敏症来袭怎么办？新型益生菌组合疗法显神效, objectType=article, longId=91058, objectId=19b2910587d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19b2910587d, replyNumber=0, likeNumber=143, createdTime=2017-05-21, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19b2910587d, moduleTitle=AJCN：过敏症来袭怎么办？新型益生菌组合疗法显神效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19b2910587d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773058, encodeId=6adb1e7305822, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=强强联手！百时美与强生合作开发免疫组合疗法Opdivo+Darzalex，治疗多种肿瘤, objectType=article, longId=86946, objectId=6e9a869465e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e9a869465e, replyNumber=0, likeNumber=88, createdTime=2017-06-28, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e9a869465e, moduleTitle=强强联手！百时美与强生合作开发免疫组合疗法Opdivo+Darzalex，治疗多种肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e9a869465e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773053, encodeId=55011e7305332, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=重磅！赛诺菲 Lantus+lixisenatide降糖组合疗法降糖效果击败 Lantus/lixisenatide单药疗法, objectType=article, longId=71369, objectId=f008e136922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f008e136922, replyNumber=0, likeNumber=140, createdTime=2016-06-26, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f008e136922, moduleTitle=重磅！赛诺菲 Lantus+lixisenatide降糖组合疗法降糖效果击败 Lantus/lixisenatide单药疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f008e136922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1773056, encodeId=d5721e73056c5, content=<a href='/topic/show?id=38b7e76380a' target=_blank style='color:#2F92EE;'>#组合疗法#</a>, objectTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, objectType=article, longId=78308, objectId=7164e8308d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7164e8308d1, replyNumber=0, likeNumber=86, createdTime=2017-04-14, rootId=0, userName=yankaienglish, userId=81db38453761, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7164e8308d1, moduleTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7164e8308d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

组合疗法

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#抗生素耐药# #组合疗法# #天然产物#

Nature：打破耐药性困局，抗生素的未来！

2024-08-18发表于上海

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Cell子刊：小分子组合疗法促进心脏再生，或可治疗心梗！

2023-03-31

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

J Dermatolog Treat："冷冻免疫治疗"是一种治疗多种常见尖锐湿疣的新组合疗法

2022-02-23

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Cancer Cell：序贯组合疗法可以使治疗对侵袭性癌症患者更有效！

2022-01-08

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Dig Dis Sci: 普瑞巴林和抗氧化剂组合疗法在减轻慢性胰腺炎疼痛中的作用

2021-01-18

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Opdivo/Cabometyx组合疗法用于一线治疗晚期肾癌的III期临床实验成功

2020-12-02

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

不一样的组合疗法——免疫治疗联合PARP抑制剂在肺癌的探索前景

2020-01-09

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

FDA授予肝癌突破性疗法：免疫+靶向治疗豪华组合疗法

2020-06-30

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

欧盟监管机构批准罗氏的组合疗法（Tecentriq、阿瓦斯汀和化疗药)用于一线治疗肺癌

2019-10-03

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Nature Reviews Drug Discovery：如何使用免疫组合疗法治疗“冷肿瘤”和“热肿瘤”？

2019-05-28

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Keytruda组合疗法治疗肝癌获FDA突破性疗法认定

2020-05-21

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

2017ASH前瞻：白血病组合疗法显疗效显著提高总生存期

2018-03-13

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

Nat Commun：加拿大科研人员发明治疗癌症的新免疫组合疗法

2018-06-29

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

新组合疗法可提升黑色素瘤治疗效果

2018-08-16

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

P53基因重排/突变的白血病非淋巴结套细胞淋巴瘤对利妥昔单抗/伊布替尼组合疗法高度敏感

2019-03-04

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

肿瘤免疫组合疗法Opdivo/NKTR-214开展5种肿瘤治疗研究

2017-03-09

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

AJCN：过敏症来袭怎么办？新型益生菌组合疗法显神效

2017-05-21

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

强强联手！百时美与强生合作开发免疫组合疗法Opdivo+Darzalex，治疗多种肿瘤

2017-06-28

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

重磅！赛诺菲 Lantus+lixisenatide降糖组合疗法降糖效果击败 Lantus/lixisenatide单药疗法

2016-06-26

yankaienglish (审核中...)

前往app查看评论内容

#组合疗法#

EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压

2017-04-14

科室
- - 订阅+
  - 更多科室
工具
服务